Literature DB >> 2204282

Beta-cell hyperresponsiveness: earliest event in development of diabetes in monkeys.

B C Hansen1, N L Bodkin.   

Abstract

Diabetes develops spontaneously in some, but not all, obese middle-aged monkeys. Longitudinal study of spontaneously obese rhesus monkeys has now shown the separation in time of the onset of various abnormalities associated with non-insulin-dependent diabetes mellitus (NIDDM). Glucose tolerance and acute and late insulin release were assessed at 6-mo to 1-yr intervals over a period of 7 yr in six young, lean, normal animals and 14 middle-aged obese, initially normoglycemic monkeys. Over 2-5 yr, while under study, five of the obese subjects developed overt diabetes [fasting plasma glucose greater than 140 mg/dl and decreased glucose disappearance rates (KG) less than 1.5]. Progressively increasing hyperinsulinemia leading to a 10-fold increase in basal plasma insulin levels (mean +/- SE = 443 +/- 69 microU/ml) and a fivefold increase in insulin response to glucose occurred independent of degree of obesity and before hyperglycemia. Later, basal and stimulated insulin levels declined before significant hyperglycemia. We conclude that in the monkey beta-cell function is clearly enhanced, not reduced, in the earliest stages of the progression to NIDDM but is reduced just before overt diabetes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2204282     DOI: 10.1152/ajpregu.1990.259.3.R612

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  24 in total

1.  Reducing Glucokinase Activity Restores Endogenous Pulsatility and Enhances Insulin Secretion in Islets From db/db Mice.

Authors:  Ishrat Jahan; Kathryn L Corbin; Avery M Bogart; Nicholas B Whitticar; Christopher D Waters; Cara Schildmeyer; Nicholas W Vann; Hannah L West; Nathan C Law; Jeffrey S Wiseman; Craig S Nunemaker
Journal:  Endocrinology       Date:  2018-11-01       Impact factor: 4.736

Review 2.  The pathogenesis of NIDDM: the role of the pancreatic beta cell.

Authors:  W S Zawalich; G G Kelley
Journal:  Diabetologia       Date:  1995-08       Impact factor: 10.122

3.  Pancreatic beta-cell failure in obese mice with human-like CMP-Neu5Ac hydroxylase deficiency.

Authors:  Sarah Kavaler; Hidetaka Morinaga; Alice Jih; WuQiang Fan; Maria Hedlund; Ajit Varki; Jane J Kim
Journal:  FASEB J       Date:  2011-02-24       Impact factor: 5.191

Review 4.  Use and Importance of Nonhuman Primates in Metabolic Disease Research: Current State of the Field.

Authors:  Peter J Havel; Paul Kievit; Anthony G Comuzzie; Andrew A Bremer
Journal:  ILAR J       Date:  2017-12-01

5.  Effects of aleglitazar, a balanced dual peroxisome proliferator-activated receptor α/γ agonist on glycemic and lipid parameters in a primate model of the metabolic syndrome.

Authors:  Barbara C Hansen; Xenia T Tigno; Agnes Bénardeau; Markus Meyer; Elena Sebokova; Jacques Mizrahi
Journal:  Cardiovasc Diabetol       Date:  2011-01-20       Impact factor: 9.951

6.  Relationship of skeletal muscle glucose 6-phosphate to glucose disposal rate and glycogen synthase activity in insulin-resistant and non-insulin-dependent diabetic rhesus monkeys.

Authors:  H K Ortmeyer; N L Bodkin; B C Hansen
Journal:  Diabetologia       Date:  1994-02       Impact factor: 10.122

Review 7.  Thiazolidinediones in prediabetes and early type 2 diabetes: what can be learned about that disease's pathogenesis.

Authors:  Jack L Leahy
Journal:  Curr Diab Rep       Date:  2009-06       Impact factor: 4.810

8.  Adipose tissue glycogen synthase activation by in vivo insulin in spontaneously insulin-resistant and type 2 (non-insulin-dependent) diabetic rhesus monkeys.

Authors:  H K Ortmeyer; N L Bodkin; B C Hansen
Journal:  Diabetologia       Date:  1993-03       Impact factor: 10.122

9.  Hyperinsulinemia is associated with altered insulin receptor mRNA splicing in muscle of the spontaneously obese diabetic rhesus monkey.

Authors:  Z Huang; N L Bodkin; H K Ortmeyer; B C Hansen; A R Shuldiner
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

10.  In vivo and in vitro increased pancreatic beta-cell sensitivity to glucose in normal rats submitted to a 48-h hyperglycaemic period.

Authors:  C Thibault; C Guettet; M C Laury; J M N'Guyen; M A Tormo; D Bailbé; B Portha; L Pénicaud; A Ktorza
Journal:  Diabetologia       Date:  1993-07       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.